FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Lincoln Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:531633 NSE Symbol: LINCOLN P/E (TTM) :13.69
ISIN Demat:INE405C01035 Div & Yield %:0.25 EPS (TTM) :43.57
Book Value (RS) :272.5891874 Market Cap (Rs Cr.):1194.47 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Dec 2023)		 Quarter Ended
(Dec 2022)		 Quarter Ended
(% Var)
Sales 146.45 133.77 9.48
Other Income 11.02 6.36 73.27
PBIDT 40.68 33.11 22.86
Interest 0.15 0.33 -54.55
PBDT 40.52 32.78 23.61
Depreciation 2.81 2.26 24.34
PBT 37.71 30.52 23.56
Tax 7.21 8.47 -14.88
Deferred Tax 2.46 0.44 459.09
PAT 28.04 21.61 29.75

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)